
Renee I. Wilson
Examiner (ID: 7319, Phone: (571)270-7896 , Office: P/2853 )
| Most Active Art Unit | 2853 |
| Art Unit(s) | 2861, 2853 |
| Total Applications | 359 |
| Issued Applications | 291 |
| Pending Applications | 0 |
| Abandoned Applications | 71 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5985877
[patent_doc_number] => 20020098538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-25
[patent_title] => '7TM receptor (AXOR23)'
[patent_app_type] => new
[patent_app_number] => 09/768703
[patent_app_country] => US
[patent_app_date] => 2001-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10795
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20020098538.pdf
[firstpage_image] =>[orig_patent_app_number] => 09768703
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/768703 | 7TM receptor (AXOR23) | Jan 23, 2001 | Abandoned |
Array
(
[id] => 6415685
[patent_doc_number] => 20020183507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-05
[patent_title] => 'Novel human GABA receptor proteins and polynucleotides encoding the same'
[patent_app_type] => new
[patent_app_number] => 09/765069
[patent_app_country] => US
[patent_app_date] => 2001-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7527
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20020183507.pdf
[firstpage_image] =>[orig_patent_app_number] => 09765069
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/765069 | Human GABA receptor proteins and polynucleotides encoding the same | Jan 17, 2001 | Issued |
Array
(
[id] => 6893969
[patent_doc_number] => 20010016335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-08-23
[patent_title] => 'Fibroblast growth factor receptor-5'
[patent_app_type] => new
[patent_app_number] => 09/758386
[patent_app_country] => US
[patent_app_date] => 2001-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 59501
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20010016335.pdf
[firstpage_image] =>[orig_patent_app_number] => 09758386
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/758386 | Fibroblast growth factor receptor-5 | Jan 11, 2001 | Abandoned |
Array
(
[id] => 5873951
[patent_doc_number] => 20020048812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-25
[patent_title] => 'Isolation and in vitro differentiation of conditionally immortalized murine olfactory receptor neurons'
[patent_app_type] => new
[patent_app_number] => 09/758257
[patent_app_country] => US
[patent_app_date] => 2001-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9516
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20020048812.pdf
[firstpage_image] =>[orig_patent_app_number] => 09758257
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/758257 | Isolation and in vitro differentiation of conditionally immortalized murine olfactory receptor neurons | Jan 11, 2001 | Abandoned |
Array
(
[id] => 988091
[patent_doc_number] => 06921646
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-07-26
[patent_title] => 'Patched genes and uses related thereto'
[patent_app_type] => utility
[patent_app_number] => 09/754032
[patent_app_country] => US
[patent_app_date] => 2001-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8509
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/921/06921646.pdf
[firstpage_image] =>[orig_patent_app_number] => 09754032
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/754032 | Patched genes and uses related thereto | Jan 2, 2001 | Issued |
Array
(
[id] => 6476235
[patent_doc_number] => 20020151692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-17
[patent_title] => 'Novel polypeptides and nucleic acids encoding same'
[patent_app_type] => new
[patent_app_number] => 09/747155
[patent_app_country] => US
[patent_app_date] => 2000-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 30708
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20020151692.pdf
[firstpage_image] =>[orig_patent_app_number] => 09747155
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/747155 | Novel polypeptides and nucleic acids encoding same | Dec 20, 2000 | Abandoned |
Array
(
[id] => 5859136
[patent_doc_number] => 20020123138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-05
[patent_title] => 'Human VNO receptor (R1)'
[patent_app_type] => new
[patent_app_number] => 09/728309
[patent_app_country] => US
[patent_app_date] => 2000-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9952
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 28
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20020123138.pdf
[firstpage_image] =>[orig_patent_app_number] => 09728309
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/728309 | Human VNO receptor (R1) | Nov 29, 2000 | Abandoned |
Array
(
[id] => 961126
[patent_doc_number] => 06951839
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-10-04
[patent_title] => 'Methods and compositions for regulating lymphocyte activity'
[patent_app_type] => utility
[patent_app_number] => 09/724964
[patent_app_country] => US
[patent_app_date] => 2000-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 25570
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/951/06951839.pdf
[firstpage_image] =>[orig_patent_app_number] => 09724964
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/724964 | Methods and compositions for regulating lymphocyte activity | Nov 27, 2000 | Issued |
Array
(
[id] => 1123060
[patent_doc_number] => 06794149
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-09-21
[patent_title] => 'GABA B receptors'
[patent_app_type] => B1
[patent_app_number] => 09/715962
[patent_app_country] => US
[patent_app_date] => 2000-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 17074
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/794/06794149.pdf
[firstpage_image] =>[orig_patent_app_number] => 09715962
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/715962 | GABA B receptors | Nov 16, 2000 | Issued |
Array
(
[id] => 1304500
[patent_doc_number] => 06616926
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-09-09
[patent_title] => 'Methods of modulating lipid metabolism and storage'
[patent_app_type] => B1
[patent_app_number] => 09/704917
[patent_app_country] => US
[patent_app_date] => 2000-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 44874
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/616/06616926.pdf
[firstpage_image] =>[orig_patent_app_number] => 09704917
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/704917 | Methods of modulating lipid metabolism and storage | Nov 1, 2000 | Issued |
Array
(
[id] => 972072
[patent_doc_number] => 06936457
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-08-30
[patent_title] => 'DNA ENCODING HUMAN α AND β SUBUNITS OF NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR, CELLS TRANSFORMED THEREWITH, AND RECOMBINANT CELL LINE EXPRESSING A HUMAN α AND β SUBUNIT OF NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR'
[patent_app_type] => utility
[patent_app_number] => 09/703951
[patent_app_country] => US
[patent_app_date] => 2000-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 18
[patent_no_of_words] => 25221
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/936/06936457.pdf
[firstpage_image] =>[orig_patent_app_number] => 09703951
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/703951 | DNA ENCODING HUMAN α AND β SUBUNITS OF NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR, CELLS TRANSFORMED THEREWITH, AND RECOMBINANT CELL LINE EXPRESSING A HUMAN α AND β SUBUNIT OF NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR | Oct 31, 2000 | Issued |
Array
(
[id] => 1588432
[patent_doc_number] => 06482612
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-19
[patent_title] => 'Adipocyte-specific protein homologs'
[patent_app_type] => B1
[patent_app_number] => 09/686838
[patent_app_country] => US
[patent_app_date] => 2000-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 32692
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/482/06482612.pdf
[firstpage_image] =>[orig_patent_app_number] => 09686838
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/686838 | Adipocyte-specific protein homologs | Oct 9, 2000 | Issued |
Array
(
[id] => 1517006
[patent_doc_number] => 06500643
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-31
[patent_title] => 'Human high affinity choline transporter'
[patent_app_type] => B1
[patent_app_number] => 09/657252
[patent_app_country] => US
[patent_app_date] => 2000-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13309
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/500/06500643.pdf
[firstpage_image] =>[orig_patent_app_number] => 09657252
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/657252 | Human high affinity choline transporter | Sep 6, 2000 | Issued |
| 09/530884 | Therapeutic methods comprising use of a neuregulin | Aug 28, 2000 | Abandoned |
| 09/582719 | Novel sequence variants of the human beta2-adrenergic receptor gene and use thereof | Aug 21, 2000 | Abandoned |
Array
(
[id] => 651090
[patent_doc_number] => 07112667
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-09-26
[patent_title] => 'Sequences of an Ih ion channel and use thereof'
[patent_app_type] => utility
[patent_app_number] => 09/640582
[patent_app_country] => US
[patent_app_date] => 2000-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 28
[patent_no_of_words] => 12031
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/112/07112667.pdf
[firstpage_image] =>[orig_patent_app_number] => 09640582
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/640582 | Sequences of an Ih ion channel and use thereof | Aug 16, 2000 | Issued |
| 09/640209 | Primate, particularly human, vomeronasal-like receptor | Aug 15, 2000 | Abandoned |
| 09/628508 | 33 Human secreted proteins | Jul 27, 2000 | Abandoned |
Array
(
[id] => 1531804
[patent_doc_number] => 06410249
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-25
[patent_title] => 'Odorant receptors'
[patent_app_type] => B1
[patent_app_number] => 09/619353
[patent_app_country] => US
[patent_app_date] => 2000-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25519
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/410/06410249.pdf
[firstpage_image] =>[orig_patent_app_number] => 09619353
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/619353 | Odorant receptors | Jul 18, 2000 | Issued |
Array
(
[id] => 7626760
[patent_doc_number] => 06768002
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-07-27
[patent_title] => 'Scorpion toxins'
[patent_app_type] => B1
[patent_app_number] => 09/599632
[patent_app_country] => US
[patent_app_date] => 2000-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 19526
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/768/06768002.pdf
[firstpage_image] =>[orig_patent_app_number] => 09599632
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/599632 | Scorpion toxins | Jun 21, 2000 | Issued |